Registration Header

Charting the Path Ahead for CBD in Dietary Supplements

A NutraIngredients-USA editorial webinar

invte a friendInvite Friends To Register

Start Date:August 22, 2019

Start Time:10:30am CT (Chicago)

Duration:60 minutes


The flood of CBD products onto the market despite the ingredient’s legal impediments has been unprecedented in the history of dietary supplements. The Hemp Farming Act, passed as part of the 2018 Farm Bill, removed the DEA hurdle for CBD (cannabidiol) from hemp. However, for FDA, the IND exclusion clause still prohibits the inclusion of CBD in dietary supplement, foods and beverages.

This has not stemmed the tide of CBD product launches, whether those are dietary supplements, beverages, or food. Quality standards appear to be all over the place, as are the claims being made. While FDA has reined in some of the more egregious players, the Agency has remained largely passive.

FDA is actively exploring potential pathways to permit certain cannabis-derived compounds in food or dietary supplements, but what are the key boxes that need to be ticked to move forward with CBD products that meet the quality standards required of mainstream products? What safety questions remain unanswered? Where do we stand on a potential NDI notification or GRAS no objection? What claims can be supported by the science? And what does the CBD space look like in five years?

In this webinar, the NutraIngredients-USA editorial team has assembled an expert panel to tell you everything you need to know about CBD.



Aaron Secrist

Vice President of NHG Quality and Regulatory Affairs

Aaron has 20+ years of experience working in all areas of QA/QC, regulatory affairs, process / product development, validation and manufacturing activities in the pharmaceutical and dietary supplement industries. Mr. Secrist has lectured extensively on regulatory and GMP related issues in both the dietary supplement and pharmaceutical industries. Aaron has been involved with numerous audits from FDA and other international regulatory agencies. He has trained hundreds of industry personnel on issues ranging from dietary supplement cGMP compliance, dietary supplement labeling compliance to GMP laboratory management. In addition, Aaron has performed hundreds of compliance audits for dietary ingredient suppliers, dietary supplement manufacturers, API manufacturers and OTC drug manufacturers.

Dr. Douglas MacKay, ND

Senior Vice President, Scientific and Regulatory Affairs
CV Sciences

Dr. MacKay oversees CV Sciences’ Science, Regulation, and Education Department, ensuring CV Sciences continues to pioneer the development of hemp-based cannabidiol (CBD) products driven by rigorous science, innovation, and regulatory compliance. Dr. MacKay brings more than 20 years of experience to CV Sciences in nutrition research, dietary supplements, health sciences and regulatory affairs. He joins CV Sciences following more than ten years with the Council for Responsible Nutrition (CRN), most recently serving as Senior Vice President of Scientific, Regulatory Affairs.

Justin J. Prochnow

Greenberg Traurig

Justin J. Prochnow assists companies with regulatory, business, and legal needs in the beverage, food, dietary supplement, cosmetic, medical device, and OTC industries. Justin works closely with companies to ensure regulatory compliance with statutes and regulations enforced by the Food and Drug Administration, the Federal Trade Commission and other regulatory agencies. This includes the review of product labels, labeling, advertising, websites and other marketing materials. Justin assists companies with responding to governmental and regulatory actions, including FDA inspections and warning letters, FTC Civil Investigative Demands, and ASRC and NAD cases. He prepares and reviews business documents for industry members, including consulting, manufacturing, supply and distribution agreements. Justin and his team also defend industry companies from both governmental agencies and civil litigators in litigation ranging from breach of contract cases to the growing number of class actions alleging false and misleading advertising.

Steven Hoffman

Compass Natural LLC

Steve serves as Founder and Managing Director of Compass Natural Marketing, a full-service public relations, marketing, brand communications, and strategic business development agency. Steve is former Editorial Director of New Hope Natural Media’s natural products trade publishing division, including the Natural Foods Merchandiser magazine. Hoffman also served as National Marketing Director and Rocky Mountain Regional Sales Manager for Arrowhead Mills, now a leading division of the Hain-Celestial Group. Steve has been tracking the hemp/CBD market from his home base in Boulder County, CO, which is one of the hotbeds of product innovation in this category.

Hank Schultz

Deputy Editor

Hank Schultz is the Senior Correspondent for NutraIngredients-USA and FoodNavigator-USA. He has experience in the dietary supplements and food business and also in the daily newspaper industry, where he was an editor with the Rocky Mountain News in Denver, Colorado.


First Name
Last Name
Email Address
Business Activity
Job Title
Company Employees
Got a burning question about this topic? Send it to us using the box below and we will try to have it answered by our expert panelists. You are also welcome to ask questions on the live day

This Editorial Webinar is a free service provided to you by NutraIngredients-USA. This service is sponsored by the partners named on this page and they would like to contact you about their products and services. Please let us know if you are happy for our partners to contact you:

By email:

NutraIngredients-USA may use your contact data to keep you informed of its products and services by email or by phone. You can withdraw your marketing consent at any time by clicking the unsubscribe link in such email or by sending an email to

More information on our processing can be found in our Privacy Notice. By submitting this form, you acknowledge that you have read and understand our Privacy Notice